Remove Clinical Trials Remove Doctors Remove Marketing Remove Pharma Companies
article thumbnail

Your HCP marketing just became harder, a lot harder

World of DTC Marketing

doctors surveyed in the same time period, 77% said their trust in the CDC has decreased and 48% said their trust in the FDA has decreased. According to Medscape, “doctors and nurses reported relatively lower trust in the CDC than WebMD readers. The result of all this is going to be widely felt in HCP marketing.

Marketing 187
article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Communicating with HCPs via email

World of DTC Marketing

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. Also, one message to ALL doctors sold not make sense. 100 percent of U.S. 100 percent of U.S.

Doctors 180
article thumbnail

Real Chemistry Introduces IRIS, an Information Hub for All Things GLP-1 Drugs

XTalks

Healthcare company Real Chemistry announced its introduction of IRIS, an insights-as-a-service platform that will deliver all things related to GLP-1 drugs. This includes news on the obesity market, the latest info on current and future GLP-1 drugs and the overall growing influence of GLP-1 therapies.

Drugs 52
article thumbnail

Edelman Trust Barometer raises questions

World of DTC Marketing

But do doctors trust the system? consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey.

article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

The sale also marks a retreat from healthcare for the tech giant, which is remarkable given that it once said it viewed health as second only to financial services market as a market opportunity. IBM said it “remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT.”

Radiology 111
article thumbnail

3 Barriers Between Patients and Clinical Research

Find Me Cure

As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .